ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EXCISION OF A MASSIVE COLONIC LESION IN A PATIENT WITH ULCERATIVE PANCOLITIS

The use of Endoscopic Submucosal Dissection (ESD) for colorectal lesions in Inflammatory Bowel Disease (IBD) remains limited. ESD offers advantages like preserving more normal mucosa, which may lessen bowel function impact and enhance quality of life in IBD patients. We present a 43-year-old man with ulcerative pancolitis who had a 110 mm laterally spreading tumor in the hepatic flexure and was recommended for colon resection. ESD in the context of IBD presents as a safe and effective method for removing large neoplastic lesions, offering the opportunity of ongoing endoscopic surveillance and organ preservation, thereby steering away from surgical intervention.